Cargando…
CXCL6 Promotes Renal Interstitial Fibrosis in Diabetic Nephropathy by Activating JAK/STAT3 Signaling Pathway
In this study the role of CXCL6 in diabetic nephropathy (DN) was investigated. It was found to be overexpression in DN patients and DN rat model. And the expression of fibrosis-related cytokines was consistent with the expression of CXCL6. High glucose significantly increased the proliferation of ra...
Autores principales: | Sun, Meng-Yao, Wang, Su-Juan, Li, Xiao-Qin, Shen, Yu-Li, Lu, Jian-Rao, Tian, Xin-Hui, Rahman, Khalid, Zhang, Li-Jun, Nian, Hua, Zhang, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442023/ https://www.ncbi.nlm.nih.gov/pubmed/30967776 http://dx.doi.org/10.3389/fphar.2019.00224 |
Ejemplares similares
-
ErHuang Formula Improves Renal Fibrosis in Diabetic Nephropathy Rats by Inhibiting CXCL6/JAK/STAT3 Signaling Pathway
por: Shen, Yu-Li, et al.
Publicado: (2020) -
Corrigendum: ErHuang Formula Improves Renal Fibrosis in Diabetic Nephropathy Rats by Inhibiting CXCL6/JAK/STAT3 Signaling Pathway
por: Shen, Yu-Li, et al.
Publicado: (2021) -
Effect of Shenkang on renal fibrosis and activation of renal interstitial fibroblasts through the JAK2/STAT3 pathway
por: Qin, Tianyu, et al.
Publicado: (2021) -
Research Progress of Chinese Herbal Medicine Intervention in Renal Interstitial Fibrosis
por: Liu, Xiao-Yuan, et al.
Publicado: (2022) -
Renoprotective Effect of the Recombinant Anti-IL-6R Fusion Proteins by Inhibiting JAK2/STAT3 Signaling Pathway in Diabetic Nephropathy
por: Zhang, Nanwen, et al.
Publicado: (2021)